B.O.; M z, W. Arginine bioavailability ratios are connected with cardiovascular mortality in sufferers referred to coronary angiography. Atherosclerosis 2011, 218, 22025. 1.Int. J. Mol. Sci. 2013,12. Marescau, B.; Nagels, G.; Possemiers, I.; de Broe, M.E.; Becaus, I.; Billiouw, J.M.; Lornoy, W.; de Deyn, P.P. Guanidino compounds in serum and urine of nondialyzed sufferers with chronic renal insufficiency. Metabolism 1997, 46, 1024031. 13. Meinitzer, A.; Puchinger, M.; Winklhofer-Roob, B.M.; Rock, E.; Ribalta, J.; Roob, J.M.; Sundl, I.; Halwachs-Baumann, G.; M z, W. Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) as well as other arginine metabolites in men following validation of a chromatographic method. Clin. Chim. Acta 2007, 384, 14148. 14. Skilton, M.R.; Serusclat, A.; Sethu, A.H.A.U.; Brun, S.; Bernard, S.; Balkau, B.; Moulin P.; Bonnet, F. Noninvasive measurement of carotid extra-media thickness: Associations with cardiovascular danger aspects and intima-media thickness. JACC Cardiovasc. Imaging 2009, two, 17682. 15. Skilton, M.R.; Sullivan, T.R.; Ayer, J.G.; Harmer, J.A.; Toelle, B.G.; Webb, K.; Marks, G.B.; Celermajer, D.S. Carotid extra-medial thickness in childhood: Early life effects on the arterial adventitia. Atherosclerosis 2012, 222, 47882. 16. Heistad, D.D.; Armstrong, M.L.; Marcus, M.L. Hyperemia on the aortic wall in atherosclerotic monkeys. Circ. Res. 1981, 48, 66975. 17. Kwon, H.M.; Sangiorgi, G.; Ritman, E.L.; McKenna, C.; Holmes D.R., Jr.; Schwartz, R.S.; Lerman, A. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia.Serplulimab J.Quercetin Clin.PMID:32261617 Invest. 1998, 101, 1551556. 18. Herrmann, J.; Samee, S.; Chade, A.; Rodriguez Porcel, M.; Lerman, L.O.; Lerman, A. Differential impact of experimental hypertension and hypercholesterolemia on adventitial remodeling. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 44753. 19. Michel, J.B.; Thaunat, O.; Houard, X.; Meilhac, O.; Caligiuri, G.; Nicoletti, A. Topological determinants and consequences of adventitial responses to arterial wall injury. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1259268. 20. Jawiska-Kozuba, A.; Martens-Lobenhoffer, J.; Surdacki, A.; Kruszelnicka, O.; Rycaj, J.; Godula-Stuglik, U.; Bode-B er, S.M. Associations involving endogenous dimethylarginines and renal function in healthy children and adolescents. Int. J. Mol. Sci. 2012, 13, 154645474. 21. Atzler, D.; Mieth, M.; Maas, R.; B er, R.H.; Schwedhelm, E. Stable isotope dilution assay for liquid chromatography-tandem mass spectrometric determination of L-homoarginine in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2011, 879, 2294298. 22. Gruber, H.J.; Mayer, C.; Meinitzer, A.; Almer, G.; Horejsi, R.; M ler, R.; Pilz, S.; M z, W.; Gasser, R.; Truschnig-Wilders, M.; et al. Asymmetric dimethylarginine (ADMA) is tightly correlated with development in juveniles with no correlations to obesity associated problems. Exp. Clin. Endocrinol. Diabetes 2008, 116, 52024. 23. Lepage, N.; McDonald, N.; Dallaire, L.; Lambert, M. Age-specific distribution of plasma amino acid concentrations within a healthful pediatric population. Clin. Chem. 1997, 43, 2397402. 24. Hammarqvist, F.; Angsten, G.; Meurling, S.; Andersson, K.; Wernerman, J. Age-related adjustments of muscle and plasma amino acids in wholesome children. Amino Acids 2010, 39, 35966. 25. Chobanyan-J gens, K.; Fuchs, A.J.; Tsikas, D.; Kanzelmeyer, N.; Das, A.M.; Illsinger, S.; Vaske, B.; Jordan, J.; L ke, T. Increased asymmetric.